World of Showjumping
World of ShowjumpingWorld of Showjumping

FEI Tribunal issues decisions on banned substance cases

Friday, 30 June 2017

The FEI Tribunal has issued its final decisions in three banned substance cases under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs). Two of these consern jumpers.

A press release from the FEI reads: 

"(...) Samples taken on 29 August 2015 from the horse Felix Van De Mispelaere (FEI ID 104JQ57/RSA), ridden by Jonathan Clarke (FEI ID RSA/10020663) to win a class at CSI1*-W in Polokwane (RSA), tested positive for the vasodilator Minoxidil.

The athlete had been provisionally suspended from 21 October 2015 until 18 May 2016. The FEI Tribunal found that while the EADCMRs were contravened, the athlete did not bear fault for the rule violation, so there was no further period of suspension imposed. He was ordered to contribute 1,000 CHF towards legal costs.

Samples taken on 14 October 2016 from the horse La Petite Fleur 6 (FEI ID 103TN40/MEX), ridden by Andres Arozarena (FEI ID MEX/10094207) at the CSI4* in Coapexpan (MEX), tested positive for the anti-inflammatory Piroxicam.

The FEI Tribunal has imposed a six-month suspension. The period of provisional suspension, effective from 20 December 2016, has been credited against the period of ineligibility imposed in this Decision. The athlete was therefore ineligible through to 19 June 2017. The athlete will also be fined 2,000 CHF and contribute 1,000 CHF towards legal costs.

Athletes have 21 days to appeal decisions to the Court of Arbitration for Sport (CAS) from the date of notification."

Further details on the FEI Tribunal Decisions can be found here.

Source: Press release from FEI / Picture © Jenny Abrahamsson

This photo has been added to your cart !

Your shopping cart »
This website is using cookies for statistics, site optimization and retargeting purposes. You consent to our cookies if you continue to use this website. Read more here.